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Abstract: The study aimed at assessing the link between physical activity (PA), sports 
activity and snus use among young men in Switzerland. Data from the Cohort Study on 
Substance Use Risk Factors (C-SURF) were used to measure PA with the International 
Physical Activity Questionnaire and sports activity with a single item. Multivariate logistic 
regression analysis was conducted to measure the association between snus use, PA and 
sports activity. Similar models were run for smoking and snuff use. Snus use increased in a 
dose-response association with PA (high level: OR = 1.72; 95% CI 1.16–2.55) and with 
individuals exercising once a week or more often (OR = 1.65; 95% CI 1.26–2.16;  
p < 0.001) or almost every day (OR = 2.27; 95% CI 1.72–3.01; p < 0.001) in separate 
models. Entered simultaneously, only sports and exercise maintained a basically 
unchanged significant dose-response relationship, whereas PA became non-significant.  
A non-significant dose-response relation was found for cigarette smoking and snuff use, 
indicating that the association with sport is specific to snus and not to tobacco use in 
general or smokeless tobacco in particular. This study showed that the association between 
snus use and sports is not specific to Nordic countries.  
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1. Introduction 
Snus is a smokeless tobacco product that seems to gain in popularity with the Swiss population [1]. 
This Swedish-type smokeless tobacco is made of moist tobacco and food additives used as flavors. It is 
available either in a loose form or packed in portions and is placed between the upper lip and the gum. 
As soon as the nicotine is humidified by the saliva, it starts to diffuse trough the mucosa into the 
systemic circulation. Regular snus users are exposed to the addictive nature of that substance as much 
as regular cigarette smokers are, maybe more [2]. 
Different forms of smokeless tobacco exist in Switzerland. While the most popular form is nasal 
snuff, i.e., mixed dry tobacco inhaled through the nose, chewing tobacco is quite uncommon.  
The prevalence of smokeless tobacco use was estimated by the Swiss tobacco control study in 2010 at 
about 2%–3% of the general population aged 14 to 65 years and up to 7.8% in men aged between  
14 to 19 [3]. In comparison, the Swedish prevalence in men aged between 24–34 reached about 34% in 
2002 [4]. Recently, based on the same sample as in the present study, i.e., young men aged around  
19–20 years in Switzerland, high prevalence rates of smokeless tobacco users were found with about 
25% having used nasal snuff in the 12 months preceding the survey and 9% snus [5]. 
The sale of snus is currently prohibited in Switzerland and the entire European Union, except 
Sweden. The Swiss health agency justifies this legislation by arguing that this product is highly 
addictive and increases the risk of oral and pancreatic cancers [6]. A gateway phenomenon—snus 
users switching to cigarette smoking—is another argument based on scientific research conducted in 
Sweden and other Nordic countries where snus is commonly used [7]. Nevertheless, importing snus for 
personal use is allowed and it can be ordered online, without effective age control. The Swiss customs 
have observed a 56-fold increase in the quantity of oral tobacco imported from Sweden between 2004 
and 2011, i.e., from 484 to 27,410 metric tons [8]. 
After it was banned in the entire European Union in 1992 Sweden is the only country in EU that is 
authorized to manufacture and sell snus. This cultural exception was made when the country joined the 
Union in 1995. With about 17% of regular smokers, Sweden has the lowest smoking prevalence in the 
EU. This may be due to the many tobacco users who rather use snus than smoke tobacco. Furthermore, 
Sweden has the lowest lung cancer prevalence in the EU. Therefore, some experts in tobacco 
prevention promote snus as a safer alternative to cigarette. Considering that snus use is less hazardous 
than tobacco smoking, they argue that substituting snus with smoked tobacco may be beneficial to 
individual and public health [9–11]. In the same line of thought, the tobacco industry along with some 
physicians, have attempted to legalize the selling of snus in Switzerland, France and  
Germany [1,12]. Despite the fact that all such initiatives have failed so far, the pressure on the 
European Commission and governments is increasing. 
Snus is very popular in sports, particularly in winter sports as ice hockey or downhill skiing [13–17]. 
In Switzerland, urine tests during the Ice Hockey World Championship performed by the Swiss  
anti-doping agency found that about 53% of the urine samples contained cotinine which is a metabolite 
of nicotine [18], suggesting a high prevalence of nicotine users among these ice hockey players.  
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As smoking is harmful to lung capacities, which are particularly essential for professional athletes, the 
authors hypothesized that the majority of the nicotine was absorbed from using smokeless tobacco. 
Nicotine may enhance physical performances by rising blood pressure, heart rate, blood sugar and 
epinephrine secretion [19–21]. 
Physical activity (PA) measures all activities such as walking or carrying loads, be it during 
working hours or leisure time. Sport and exercise is different from physical activity because it is a 
specific part of everyday physical activity [15]. If you play ice hockey twice a week in addition to 
doing fitness training once a week with the aim of improving physical fitness and playing capacities, it 
is considered as a planned physical activity. In that regard, it is different from everyday physical 
activity. This means, for example, that a mason certainly spends more energy and has a higher physical 
activity (PA) level than a clerk playing football two hours a week. 
First, the present study aims at testing whether there is an association between snus use and the 
level of physical activity, and sport and exercise in a population of young men in Switzerland, i.e., in a  
non-Scandinavian country. Second, it also aims at testing whether the association with physical 
activity is mainly due to doing sports and exercise and not physical activity in general. Third, it 
investigates whether the association is found particularly for snus and not for smoking or the most 
common smokeless tobacco, namely snuff. 
2. Methods 
Army recruitment is mandatory in Switzerland for over 18-year-old males, who must undergo a 
two-hour assessment of their physical and mental aptitude for either military or civil service.  
During this medical test, virtually all young men were invited to participate in the Cohort Study on 
Substance Use Risk Factors (C-SURF) between August 2010 and November 2011 in the recruitment 
centers of Lausanne (French-speaking part of Switzerland), Windisch and Mels (both in the  
German-speaking part). While army recruitment centers were used to inform and enroll participants, 
the C-SURF study was independent from the army. During this period, 13,245 men were invited to 
participate in this study. Of these, 7564 (57.1%) men gave written informed consent. A few days after 
consenting, a one-hour long questionnaire was sent by email or by post to participants, and was filled 
out by 5987 men, thus reaching a 79.1% response rate. The research protocol (15/07) of the study was 
approved by the Ethics Committee for Clinical Research of the Lausanne University Medical School. 
The present study used data from the baseline assessment only. 
To begin with, 244 participants (4.1% of the respondents) were excluded because of incomplete 
data on PA, sports activity or exercise, smokeless tobacco use or background variables. As daily snus 
users were few, snus use was categorized into “less than weekly” or “at least weekly”. Additionally, 
nasal snuff use was measured in order to test whether associations with physical activity and sport and 
exercise were unique to snus among smokeless tobacco users. Nasal snuff has been shown [5] to be the 
most common smokeless tobacco product used by this population. Snuff use was categorized into “less 
than weekly”, “weekly and more often”. As chewing tobacco is very uncommon in Switzerland [3],  
it was not included in the present study. Pictures in the questionnaire helped participants distinguish 
between the different forms of smokeless tobacco. 
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In order to measure self-reported PA, the short form of the International Physical Activity 
Questionnaire (IPAQ) was used. A multicenter study indicated that this instrument has good 
measurement properties, at least as good as other established self-reports [22]. Following the IPAQ 
guidelines for data processing and analysis [23], we removed 376 (6.3%) participants with unreliable 
data, e.g., subjects having more than 16 hours of physical activity per day. Reported PA of less than 10 
min duration was assigned a zero value in 159 cases. As a result, the final analytic sample consisted of 
5367 subjects. 
Participants’ PA was categorized into three levels following the IPAQ guidelines: Low, moderate 
and high. The IPAQ guidelines suggest the metabolic equivalent or MET-minute unit to define these 
categories. Minutes of walking are calculated with a coefficient of 3.3, minutes of moderate PA (such 
as carrying light loads or playing golf) are multiplied by 4.0 and minutes of vigorous PA (as playing 
ice hockey or another intense sport practice) by 8.0. Daily physical activity and a sum of  
3000 MET-minutes/week or vigorous PA at least three times a week achieving at least  
1500 MET-minutes/week define the high level of physical activity. A moderate level of physical 
activity is described either as vigorous physical activity at least 20 min/day three days a week, or as 
moderate and walking activity during at least 30 min 5 days/week, or as any combination of physical 
activity amounting to at least 600 MET-minutes/day 5 days/week. Any activity below the limit of 
moderate PA was categorized into the low level. PA includes any activity during work, leisure time or 
at home. Although IPAQ is a widely used instrument, it does not distinguish between sports activity 
and other physical activities. Therefore, a single question served to assess sports activity or exercise: 
“Over the past twelve months, how often did you do sports or exercise?” Participants could choose 
between five answers: 1 = never, 2 = a few times per year, 3 = 1 to 3 times per month, 4 = at least once 
per week or 5 = almost every day. Sport and exercise were recoded into three levels: 1. Less than once 
a week; 2. Once a week or more; 3. Almost every day. 
Based on the literature review, six different variables exploring the socio-demographic background 
of the participants and their smoking habits were used to adjust for potential confounders. Beside age 
and language (questionnaires were available in French and German), the socio-economic status was 
determined by the family income, which was divided into “below average”, “average” or “more than 
average”, according to the questionnaire of the European School Survey on Alcohol and Other Drugs [24]. 
Education level was assessed on the highest level achieved: “Primary schooling” (9 years), “vocational 
training” (>9–12 years) or “post-secondary” (13 years or more, including high school, which can be 
only 12 years in some Swiss cantons). Cigarette smokers were classified into “non-smokers”, 
“occasional smokers” and “daily smokers“. Finally, cannabis users in the past 12-months were 
categorized into “non-users”, “less than twice a week” users and “twice a week users or more often”. 
Standard descriptive statistics were conducted to characterize the sample and to compare the levels 
of physical activity, sport and exercise according to snus and snuff use. A chi-squared test for 
categorical variables and t-tests for the continuous age variable were used. 
Following to the descriptive analysis, unadjusted associations of physical activity and sport and 
exercise were tested using simple logistic regression models. Then, three multiple logistic regression 
models, adjusted for age, language, income, education level, cigarette and cannabis use, were 
performed. The first model compared physical activity levels according to snus use. The second model 
compared sport and exercise levels. Finally, the third model tested the associations of physical activity 
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and sport and exercise with snus simultaneously, in order to examine the unique contribution of 
physical activity and sport and exercise. Low physical activity and less than weekly sport and exercise 
were set as reference groups. The same set of logistic regression models was performed for snuff use 
and cigarette smoking (occasional and daily smokers grouped together vs. non-smokers). This was 
done to investigate whether findings were specific to snus and not related to tobacco use in general or 
smokeless tobacco use in particular. For analyses on cigarette smoking, models were adjusted for the 
use of snus instead of smoking. Due to the small sample size, frequencies of snus and snuff use over the 
past 12 months were combined, and snus or snuff users over the past 12 months were compared to  
non-users. Odds ratios (OR) with a 95% confidence interval (95% CI) were presented. Analysis was 
conducted using the SPSS 21 software (IBM Corp., Armonk, NY, USA). 
3. Results 
Table 1 displays the demographic characteristics of the sample. Mean age (standard deviation) was 
20.00 (1.24) at baseline. Of the 5367 analyzed questionnaires, 532 (9.9%) were categorized into the 
low level of PA, 1357 (25.3%) into the moderate and 3478 (64.8%) into the high level. In total,  
372 (6.9%) used snus less than weekly and 112 (2.1%) weekly or more and 269 (72.3%) and 83 
(74.1%) of them, respectively, were found in the high PA category.  
Table 1. Participants’ characteristics by snus use in the past 12 months. 
 
12-month Snus Use 
Total  
(N = 5367) 
No Use  
(N = 4883; 91.0%) 
Less than Weekly Use 
(N = 372; 6.9%) 
Weekly or More Use 
(N = 112; 2.1%) p 
N % N % N % N % 
Physical activity         0.001 
Low 532 9.9 502 10.3 20 5.4 10 8.9  
Moderate 1357 25.3 1255 25.7 83 22.3 19 17.0  
High 3478 64.8 3126 64.0 269 72.3 83 74.1  
Sports and exercise         <0.001 
Less than once a week 1515 28.2 1426 29.2 75 20.2 14 12.5  
Once a week or more 2226 41.5 2009 41.1 169 45.4 48 42.9  
Almost every day 1626 30.3 1448 29.7 128 34.4 50 44.6  
Age (Mean, SD) 20.00 1.24 20.02 1.25 19.75 1.19 19.68 0.87 <0.001 
Language         <0.001 
German 2381 44.4 2072 42.4 234 62.9 75 67.0  
French 2986 55.6 2811 57.6 138 37.1 37 33.0  
Family income         0.057 
Below average 774 14.4 720 14.7 46 12.4 8 7.1  
Average 2203 41.0 2010 41.2 150 40.3 43 38.4  
Above average 2390 44.5 2153 44.1 176 47.3 61 54.5  
Highest achieved education         0.068 
Primary schooling 2621 48.8 2361 48.4 193 51.9 67 59.8  
Vocational training 1556 29.0 1425 29.2 101 27.2 30 26.8  
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Table 1. Cont. 
 
12-month Snus Use 
Total  
(N = 5367) 
No Use  
(N = 4883; 91.0%) 
Less than Weekly Use 
(N = 372; 6.9%) 
Weekly or More Use 
(N = 112; 2.1%) p 
N % N % N % N % 
Post-secondary 1190 22.2 1097 22.5 78 21.0 15 13.4  
Cigarette smoking         <0.001 
Non-smoker 2834 52.8 2711 55.5 79 21.2 44 39.3  
Occasional smoker 1437 26.8 1213 24.8 174 46.8 50 44.6  
Daily smoker 1096 20.4 959 19.6 119 32.0 18 16.1  
Cannabis use         <0.001 
Non-user 3720 69.3 3458 70.8 189 50.8 73 65.2  
Less than twice a week 1150 21.4 982 20.1 137 36.8 31 27.7  
Twice a week or more 497 9.3 443 9.1 46 12.4 8 7.1  
SD = Standard deviation. 
Table 2. Participants’ characteristics by snuff use in the last 12 months (N = 5367). 
 
No Use  
(N = 4118; 76.7%) 
Less Than Weekly Use 
(N = 1063; 19.8%) 
Weekly or More Use  
(N = 186; 3.5%) p 
N % N % N % 
Physical activity       <0.001 
Low 421 10.2 98 9.2 13 7.0  
Moderate 1081 26.3 248 23.3 28 15.1  
High 2616 63.5 717 67.5 145 78.0  
Sports and exercise       0.007 
Less than once a week 1196 29.0 267 25.1 52 28.0  
Once a week or more 1653 40.1 492 46.3 81 43.5  
Almost every day 1269 30.8 304 28.6 53 28.5  
Age (Mean, SD) 20.08 1.29 19.74 1.02 19.64 1.05 <0.001 
Language       <0.001 
German 1678 40.7 579 54.5 124 66.7  
French 2440 59.3 484 45.5 62 33.3  
Family income       0.092 
Below average 607 14.7 140 13.2 27 14.5  
Average 1705 41.4 413 38.9 85 45.7  
Above average 1806 43.9 510 48.0 74 39.8  
Highest achieved education       <0.001 
Primary schooling 1943 47.2 562 52.9 116 62.4  
Vocational training 1194 29.0 305 28.7 57 30.6  
Post-secondary 981 23.8 196 18.4 13 7.0  
Cigarette smoking       <0.001 
Non-smoker 2453 59.6 314 29.5 67 36.0  
Occasional smoker 880 21.4 477 44.9 80 43.0  
Daily smoker 785 19.1 272 25.6 39 21.0  
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Table 2. Cont. 
 
No Use  
(N = 4118; 76.7%) 
Less Than Weekly Use 
(N = 1063; 19.8%) 
Weekly or More Use  
(N = 186; 3.5%) p 
N % N % N % 
Cannabis use       <0.001 
Non-user 3004 72.9 598 56.3 118 63.4  
Less than twice a week 726 17.6 365 34.3 59 31.7  
Twice a week or more 388 9.4 100 9.4 9 4.8  
SD = Standard deviation. 
 
Concerning sport and exercise, 1515 (28.2%) exercised less than once a week, 2226 (41.5%) once a 
week or more and 1626 (30.3%) almost every day. In the latter category, 34.4% (n = 128) used snus 
less than weekly and 44.6% (n = 50) weekly and more. With regard to cigarette smoking, 79 (21.2%) 
of less than weekly snus users and 44 (39.3%) of weekly or more often snus users were non-smokers. 
Table 2 presents the descriptive characteristics of snuff users for comparison. 
Results of the logistic regression models testing the associations of physical activity and sport and 
exercise with snus use are reported in Table 3. Models 1 and 2 tested the association of snus use with 
PA and sport and exercise, respectively. All were adjusted for age, language, income, education level, 
cigarette and cannabis use. The odds ratio (OR) for snus use increased in a dose-response association 
with physical activity, although only high PA significantly differed from low PA with an OR of 1.88 
(95% CI 1.28–2.77) in the unadjusted model and an OR of 1.72 (95% CI 1.16–2.55) in model 1. 
Similarly, a dose-response association was found for sport and exercise with individuals exercising 
once a week or more (OR = 1.73; 95% CI 1.34–2.23; p < 0.001, for unadjusted model, OR = 1.65; 
95% CI 1.26–2.16; p < 0.001, for model 2) and almost every day (OR = 1.97; 95% CI 1.51–2.57;  
p < 0.001, for unadjusted model, OR = 2.27; 95% CI 1.72–3.01; p < 0.001, for model 2) and being 
significantly more likely to use snus than those exercising less than once a week. In model 3, where 
PA and sport and exercise were entered simultaneously, the same dose-response association was found 
between snus use and sport and exercise. The OR remained significant and practically unchanged  
(OR = 1.59; 95% CI 1.21–2.08; p < 0.001, for once a week or more and OR = 2.10; 95% CI 1.57–2.81;  
p < 0.001, for almost every day sport or exercise). By contrast, the association between PA and snus 
use turned out to be non-significant and both moderate PA (OR = 1.19; 95% CI 0.77–1.83; p = 0.442) 
and high PA (OR = 1.36; 95% CI 0.91–2.04; p = 0.134) did not significantly differ from low PA. 
With regard to analyses of cigarette smoking, the only significant association of PA was found for 
high PA as opposed to low PA (OR = 1.39; 95% CI 1.12–1.73; p = 0.003) in model 3. However, this 
difference was neither significant in the unadjusted model neither in model 1. By contrast, sport and 
exercise was significantly negatively related with cigarette smoking. Participants who reported doing 
sport and exercise once a week or more (unadjusted model: OR = 0.82; 95% CI 0.72–0.94; p = 0.003, 
model 2: OR = 0.85; 95% CI 0.73–0.99; p = 0.041, model 3: OR = 0.81; 95% CI 0.70–0.95; p = 0.008) 
and almost every day (unadjusted model: OR = 0.50; 95% CI 0.0.43–0.58; p < 0.001, model 2:  
OR = 0.53; 95% CI 0.45–0.63; p < 0.001, model 3: OR = 0.47; 95% CI 0.39–0.56; p = 0.008) were less 
likely to smoke cigarettes, as compared with those who reported doing sport and exercise less than 
once a week.  
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Table 3. Logistic regression for snus, cigarette and snuff use in association with physical activity and sports and exercise. 
 
Unadjusted Model Model 1 Model 2 Model 3 
OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p 
Snus use             
Physical activity   <0.001 a   0.004 a      0.227 a 
Low 1.00   1.00      1.00   
Moderate 1.36 0.89–2.07 0.151 1.29 0.84–1.99 0.239    1.19 0.77–1.83 0.442 
High 1.88 1.28–2.77 0.001 1.72 1.16–2.55 0.007    1.36 0.91–2.04 0.134 
Sports and exercise   <0.001 a      <0.001 a   <0.001 a 
Less than once a week 1.00      1.00   1.00   
Once a week or more 1.73 1.34–2.23 <0.001    1.65 1.26–2.16 <0.001 1.59 1.21–2.08 <0.001 
Almost every day 1.97 1.51–2.57 <0.001    2.27 1.72–3.01 <0.001 2.10 1.57–2.82 <0.001 
Cigarette smoking             
Physical activity   0.436 a   0.638 a      <0.001 
Low 1.00   1.00      1.00   
Moderate 1.13 0.92–1.38 0.243 1.01 0.80–1.27 0.937    1.08 0.85–1.36 0.538 
High 1.12 0.94–1.35 0.209 1.07 0.87–1.32 0.515    1.39 1.12–1.73 0.003 
Sports and exercise   <0.001 a      <0.001   <0.001 
Less than once a week 1.00      1.00   1.00   
Once a week or more 0.82 0.72–0.94 0.003    0.85 0.73–0.99 0.041 0.81 0.70–0.95 0.008 
Almost every day 0.50 0.43–0.58 <0.001    0.53 0.45–0.63 <0.001 0.47 0.39–0.56 <0.001 
Snuff use             
Physical activity   0.002 a   0.042 a      0.041 a 
Low 1.00   1.00      1.00   
Moderate 0.97 0.76–1.24 0.799 0.92 0.71–1.19 0.521    0.90 0.69–1.17 0.417 
High 1.25 1.00–1.56 0.050 1.13 0.89–1.42 0.322    1.11 0.87–1.42 0.389 
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Table 3. Cont. 
 Unadjusted Model Model 1 Model 2 Model 3 
 OR 95% CI p OR 95% CI p OR 95% CI p OR 95% CI p 
Sports and exercise   0.001 a      0.148 a   0.144 a 
Less than once a week 1.00      1.00   1.00   
Once a week or more 1.30 1.11–1.52 0.001    1.18 0.99–1.39 0.053 1.16 0.98–1.37 0.093 
Almost everyday 1.05 0.89–1.25 0.540    1.09 0.90–1.31 0.367 1.02 0.84–1.24 0.858 
Model 1: Association of physical activity, adjusted for age, language, family income, highest achieved education, cigarette smoking (only for snus and snuff use), snus 
(only for cigarette smoking), cannabis use; Model 2: Association of sports and exercise, adjusted for age, language, family income, highest achieved education, cigarette 
smoking (only for snus and snuff use), snus (only for cigarette smoking), cannabis use; Model 3: Associations of physical activity and sports and exercise, adjusted for 
age, language, family income, highest achieved education, cigarette smoking (only for snus and snuff use), snus (only for cigarette smoking), cannabis use. OR = Odds 
Ratio; 95% CI = 95% confidence interval. a p value for overall factor. 
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Furthermore, no dose-response association of snuff use was found with PA and sport and exercise. 
In Model 1 high and moderate PA did not significantly differ from low PA. The same result was found 
when comparing those exercising once a week or more or almost every day with those exercising less 
than a week as shown in model 2. Model 3, testing the associations of PA and sport and exercise 
simultaneously, yielded similar non-significant results. 
 
4. Discussion 
The present study showed an association between snus use and a high level of physical activity and 
an even stronger association with sport and exercise in a population of young men in Switzerland.  
When tested simultaneously, odds ratios showed a significant association between snus and sport and 
exercise, but PA was no longer significant. This result suggests that the link between PA and snus use 
is mainly mediated through sport and exercise. Although sport and exercise is part of PA, it is 
important to distinguish the effects of sport from those of PA through other activities in order to better 
understand its association with substance use [15]. Indeed, the results of the present study showed that 
the association of snus use with sport and exercise is more relevant than with PA in general. 
No association was found between nasal snuff and physical activity nor with sport and exercise, 
which indicates that the association does not exist with smokeless tobacco use in general, but with snus 
use in particular. This suggests that, despite the higher prevalence of snuff use, snus use may be 
associated with physical activity and sport or exercise. In addition, sport and exercise were negatively 
associated with cigarette smoking, indicating that the association between snus and sport and exercise 
was not due to tobacco use in general. 
To our knowledge, this is the first study exploring the association between PA and snus use in 
Europe outside the Nordic countries. A previous study analyzed the relationship between sports 
activity and snus use in Finland [17]. The authors found odds ratios of 1.7 (95% CI 1.2–2.2) for light 
physical activity (less than 5 h/week), 3.6 (95% CI 2.8–4.8) for moderate physical activity (around  
5 h/week) and 10.2 (95% CI 7.8–13.5) for regular competitive sports activity. In addition, the present 
study found a much higher proportion of participants categorized in the highest level of physical activity 
compared with the Finnish study. This result may be due to the use of a different measure of PA assessed 
by the IPAQ questionnaire, which allows a combination of moderate- and vigorous-intensity activities to 
meet the highest activity level [23]. Indeed, the association of snus use with PA could be identified 
already in descriptive statistics, i.e., the percentage of individuals with the highest level of sports 
activity and exercise practice (almost daily practice): 30.3% in the total sample, compared with 29.7% 
with no snus use, 34.4% with less than weekly snus use and 44.6% with weekly snus use. Thus, the 
present study confirmed the dose-response relationship between physical activity and even more so 
with sport or exercising found by Mattila et al. [17]. 
The increasing amount of imported snus in Switzerland reported by the customs supports the 
hypothesis that snus gains in popularity in Switzerland and is used as in Nordic countries by the young 
and physically active population. Different studies conducted in France helped explain how this 
phenomenon of snus use was imported into other European countries from the Nordic countries.  
As snus is popular in winter sports, particularly among semi- and professional athletes [18],  
Bujon et al. [12,14] showed how this trend was brought into winter sports resorts where young people 
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were in contact with these athletes. Young adults seeing their peers taking snus will be more likely to 
engage in the same behavior than if they had not been in contact with them. This could indicate that 
not only snus, but also its association with sports activities may be imported from Sweden. A previous 
Norwegian study found that the prevalence of snus use was almost three times higher for athletes 
competing in team sports such as ice hockey than individual sports (OR = 2.8, 95% CI 1.6 to 4.7) [25]. 
Like in Nordic countries, ice hockey is very popular in Switzerland and even if our study design does 
not permit us to identify specific sports activities, we speculate that the high popularity of winter sports 
such as ice hockey in Switzerland is a fertile ground for snus use. 
Another outcome of our study is the high proportion of smokers that we found among snus users. 
Other studies found this association between smoked and smokeless tobacco products [26,27]. Although 
the aim of this study was not to explore the gateway phenomenon, results of the present study showed 
that only 21.2% of less than weekly snus users and 39.3% of weekly or more snus users were  
non-smokers compared with 55.5% among non-users of snus. Even though our study design does not 
permit a definite answer, this calls for caution as regards research supporting that snus could be a less 
harmful alternative to smoked tobacco. This seems unlikely to be the case in Switzerland, where snus 
is used in addition to smoked tobacco, and may not be used as a nicotine substitute for cigarettes or other 
smoked tobacco products. 
One of the strengths of our study is the large sample size. Every Swiss man has to go through the 
mandatory army recruitment process, allowing us to obtain a representative sample of the whole  
20-year-old male population in Switzerland. This study also has limitations. First, the cross-sectional 
design does not allow to draw causal conclusions. The longitudinal nature of the cohort study, 
however, will, in the near future, make it possible to measure the pathways from snus use to the use of 
other tobacco products, for example. Second, the present study is limited to a young male population 
and therefore no conclusions can be drawn about the behavior of females and older populations. Third, 
all data was obtained by means of a self-reported questionnaire. However, a previous study showed 
that young people tend to provide valid information about their use of tobacco products in self-reported 
questionnaires [28]. Fourth, no question about specific sports activities such as playing ice hockey was 
asked at baseline. Therefore no data was available to show whether snus use was specific to ice hockey 
players, for example. Nevertheless, self-reported data about sport and exercise enabled the assessment 
of regular sports activities in young men. Finally, the relatively high number of excluded 
questionnaires because of unreliable data following the IPAQ analyzing guidelines is another 
limitation of the study. 
5. Conclusions 
The present study confirmed that, as found in Nordic countries, snus use was associated with sport 
and exercise or with physical activity in Switzerland, where access to snus is legally prohibited.  
This may suggest that a particular marketing image associating snus with sports activities has been 
exported from Sweden to other countries. Therefore, snus use should be monitored, particularly among 
the physically active young population, and probably even more so among those practicing winter 
sports, in order to see whether it gains in popularity as it does in Nordic countries. 
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